Best practice in precision medicine for prostate cancer
Dr Gil Morgan from OncoAlert gives his oncology highlights from social media for the week of September 26th - October 4th.
Dr Morgan covers papers from The New England Journal of Medicine, Annals of Oncology, Cancer Cell, The Lancet Oncology, The Journal of Precision Oncology, The Journal of Clinical Oncology.
He also covers FDA approval news, COVID-19 best practice reminders and gives the details of the Kidney Cancer Research Summit on the 22nd October.
Follow Dr Morgan on twitter.
Follow ecancer on twitter.
Best practice in precision medicine for prostate cancer
Key insights from lung cancer research at ASCO 2025
ELCC 2025: Latest in EGFR positive NSCLC
ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer
ESMO 2024: Highlights and analysis
ASCO 2024: Lung cancer highlights
EAU 2024: Bladder cancer latest
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
Multiple myeloma (A cancer arising from plasma cells)